Clintrak Pharmaceutical Services, LLC (CPS) Signs Lease for its Freiburg, Germany Facility and Establishes Clintrak Pharmaceutical Services GmbH as its European Base of Operation

Applied Clinical Trials

CPS is pleased to announce that it has agreed to terms and signed the lease for its new facility in Freiburg, Germany.

23 May 2005 -- Freiburg, Germany: CPS is pleased to announce that it has agreed to terms and signed the lease for its new facility in Freiburg, Germany. The state-of-the-art facility is approximately 3,500 m2 (35,000 ft. 2) and will require minor modifications to become fully operational as the company's Clinical Trial Material (CTM) Packaging and Logistics center in Europe. The company will also be housing its European label reprinting capability from this site which will allow it to provide reprints of all labels including its flagship GlobalPly Booklet Labels. CPS anticipates that the facility will be available for audits by 1 August 2005. The new facility will be known as CPS GmbH.

In addition to the facility, the third version of the company's proprietary Clinical Trial Material Software (CTMS) will be completed and validated. CTMS 3.0 will encompass all requirements for the German facility as well as additional functionality for on-going operations. The software, which is compliant with 21 CFR Part 11, will manage all areas of the company's operation and provides seamless data for the company's clients. Brian Jusas, CEO, stated "the ability to utilize CTMS for all activities within our CTM operations, at both sites, is critical in providing clean, real-time data that has not been transferred or manipulated prior to provision to our clients."

Philippe Muller, who has joined the organization as Director, Qualified Person is very excited with the new facility stating "the acquisition of this facility will allow CPS to move rapidly to service the needs of the CTM industry throughout Europe".

CPS is a privately held company which provides CTM Label and Logistics solutions to Pharmaceutical and Biotechnology industry.

For more information, please contact Charles J. Gettis, Vice President, Corporate Development at cgettis@acculogix-usa.com or +215.826.8002 or Philippe Muller, Director, Qualified Person at +49 76150380.